Published on 19 Aug 2024 on Benzinga · via Yahoo Finance
Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests
Friday, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) reiterated its commitment to advancing the development of its live attenuated virus vaccine, TNX-801 (recombinant horsepox virus), to prevent mpox and other infectious diseases.
As per data from Benzinga Pro, Tonix Pharmaceuticals has a strong session volume of 53.33 million on Friday.